Catalent Pharma Solutions‘ pharmaceutical softgel facility in Buenos Aires, Argentina has successfully completed its first FDA general cGMP audit and pre-approval inspection, with no reported observations on FDA Form 483. Catalent has been operating in Argentina since 1953 serving local and regional pharmaceutical and consumer health markets, and is completing a substantial expansion of the facility designed to meet FDA and other global regulatory standards. Catalent now has 20 sites a...